The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01332968
Brief Title: A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)

First Submitted : April 8, 2011
First Submitted that Met QC Criteria : April 8, 2011
First Posted : April 11, 2011 (Estimate)

Results First Submitted : February 3, 2017
Results First Submitted that Met QC Criteria : May 5, 2017
Results First Posted : June 7, 2017

Last Update Submitted that Met QC Criteria : August 9, 2022
Last Update Posted : August 11, 2022